Medicxi Ventures Management (Jersey)
$177M 13F equity value
4 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Medicxi Ventures Management (Jersey) covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| PHAT | PHATHOM PHARMACEUTICALS INC | 7,464,572 | $81M | 45.6% |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 2,208,639 | $75M | 42.2% |
| AURA | AURA BIOSCIENCES INC | 3,039,892 | $22M | 12.2% |
| CNTA | CENTESSA PHARMACEUTICALS PLC |
Track Medicxi Ventures Management (Jersey)'s 13F portfolio: $177M in reported holdings, 4 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}